It has been a busy few months for James and the team. The molecular research is coming along steadily. The team has been granted full ethics approval, and is currently in the process of getting the governance paperwork sorted for each of the participating hospitals. In addition, they are building a REDCap database to facilitate online data collection across sites. Through our preliminary testing, the team has made a decision to sequence the samples using the ArcherDX platform (https://archerdx.com/). To that end, they submitted an application for a grant offered by the company in a bid to offset the high cost of sequencing, and effectively allow The Aftershock donation to go even further.
While a lot of work is in progress for main molecular project, the team has presented our clinical studies in several meetings this year, including the Academic Surgical Congress in Houston, where James represented the Royal Australasian College of Surgeons as the recipient of the Younger Fellows Leadership Exchange; and the Royal Australasian College of Surgeons Annual Scientific Congress in Bangkok; and a poster was presented at the Alfred Hospital Research Week 2019. Finally, James was recently featured in the Surgical News of the College.
Thank you to The Aftershock and your donors for being part of this exciting endeavour to Change It. For Good.